Day

juli 28, 2018
SAN DIEGO and COPENHAGEN, Denmark, July 23, 2018 /PRNewswire/ — Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b clinical trial of Rivelin® Clobetasol patch (Rivelin®-CLO) for oral lichen planus (OLP). Rivelin-CLO is the first biodegradable oral adhesive patch designed for local delivery of clobetasol...

Nyheder

Danske forskere bringer nyt om overvældende søvntrang 
19. februar 2019
Hidtil største studie knytter såkaldt kattelort-parasit til skizofreni
2. februar 2019
Forskere finder sammenhænge mellem psykiatriske lidelser og begivenheder i fostertilstanden
28. januar 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge